This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: George Henry Poste: Innovator in Adrenomedullin Receptor Research
Introduction
George Henry Poste is a notable inventor based in Dover, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of receptor polynucleotides. His work has implications for various medical conditions, showcasing the potential of innovative treatments.
Latest Patents
George Henry Poste holds a patent for "Adrenomedullin receptor polynucleotides." This patent discloses putative Adrenomedullin receptor polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. The patent also outlines methods for utilizing these polypeptides and polynucleotides in designing protocols for treating infections, including bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV-1 or HIV-2. Additionally, it addresses treatments for pain, cancers, diabetes, obesity, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure, and various other conditions.
Career Highlights
Throughout his career, George Henry Poste has focused on advancing medical research and developing innovative solutions for complex health issues. His patent reflects a deep understanding of molecular biology and its applications in medicine.
Collaborations
George has collaborated with notable professionals in his field, including Eve Mahe and Philippe Laurent Robert. These collaborations have likely contributed to the depth and breadth of his research.
Conclusion
George Henry Poste's work in the field of adrenomedullin receptor research exemplifies the impact of innovation in medicine. His contributions pave the way for potential advancements in treating various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile